Filing Details

Accession Number:
0001127602-11-005902
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-16 20:27:02
Reporting Period:
2011-02-15
Filing Date:
2011-02-16
Accepted Time:
2011-02-16 20:27:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
850693 Allergan Inc AGN Pharmaceutical Preparations (2834) 951622442
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219890 Alexander Robert Ingram 2525 Dupont Drive
Irvine CA 92612
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-02-15 10,800 $73.61 14,564 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $73.5601 to $73.6501, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote.